Showing 151-160 of 3104 results for "".
Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-dementia-and-psychosis-in-individuals-with-parkinson-disease/39935/Jorge Patino, MD, Movement Disorders Fellow, University of Cincinnati, Cincinnati, OH, provides an overview of dementia and psychosis in people with Parkinson disease, including clinical approaches for the diagnosis of these conditions, and nonpharmacologic, environmental, and pharmacologic treatmenHow to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
https://practicalneurology.com/videos/neurology-in-motion/how-to-communicate-the-results-of-alzheimer-disease-biomarker-tests-with-patients/39733/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses how to communicate the results of Alzheimer disease biomarker tests with patients.Factors Influencing the Selection of Blood Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-blood-tests-for-alzheimer-disease/39224/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of blood tests for Alzheimer disease.Young-Onset ALS: Diagnosis and Research
https://practicalneurology.com/diseases-diagnoses/neuromuscular/young-onset-als-diagnosis-and-research/30098/In this episode, Gwen Petersen discusses her long journey to receiving an ALS diagnosis at age 32, her contributions to a Cytokinetics book project, and the importance of clinical trial participation. We are also joined by Merit Cudkowicz, MD, MSc, Head of the Department of Neurology, Chief of NeuroCerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations
https://practicalneurology.com/diseases-diagnoses/stroke/cerebrovascular-inflammatory-conditions-diagnostic-challenges-and-treatment-considerations/36478/Abbas Kharal, MD, MPH, Neurologist at Cleveland Clinic Neurological Institute, Cleveland, OH, provides a review of cerebrovascular inflammatory conditions, with an emphasis on diagnostic challenges, the evolving treatment landscape, and the use of imaging and clinical responses to assist cliniciansSeeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin TherapeuticsNeurology Q&A: What Neurologists Should Know About Headache Patients and Complimentary Medicine
https://practicalneurology.com/diseases-diagnoses/headache-pain/neurology-qa-what-neurologists-should-know-about-headache-patients-and-complimentary-medicine/30804/Those who suffer from headaches may be more likely to use CAM than others are. Here's what research shows.A Q&A with Rebecca E. Wells, MD, MPHAbout the Cover Artist
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/audrius-v-plioplys-md-is-a-neurologist-who-has-merged-the-research-lab-with-the-art-studio/31667/Audrius V. Plioplys, MD, is a neurologist who has merged the research lab with the art studio.Concussion and Epilepsy: What is the Link?
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/concussion-and-epilepsy-what-is-the-link/30769/Individuals who suffer a traumatic brain injury are at increased risk for developing seizures. Here's an update to the current evidence and implications for monitoring.Insights from G. Alexander Hishaw, MDAdvancing MOGAD Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advancing-mogad-care/60954/What do the latest METEOROID trial results mean for neurologists treating myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)? Michael Levy, MD, Massachusetts General Hospital, Boston, MA, discusses relapse prevention, diagnostic challenges, and the future of MOGAD management wit